Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AC Immune (ACIU) Shares Outstanding (2017 - 2025)

AC Immune (ACIU) has disclosed Shares Outstanding for 9 consecutive years, with $127.3 million as the latest value for Q4 2025.

  • Quarterly Shares Outstanding rose 11.06% to $127.3 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $127.3 million through Dec 2025, up 11.06% year-over-year, with the annual reading at $127.3 million for FY2025, 11.06% up from the prior year.
  • Shares Outstanding for Q4 2025 was $127.3 million at AC Immune, up from $114.6 million in the prior quarter.
  • The five-year high for Shares Outstanding was $127.3 million in Q4 2025, with the low at $86.8 million in Q4 2022.
  • Average Shares Outstanding over 5 years is $106.2 million, with a median of $111.8 million recorded in 2023.
  • The sharpest move saw Shares Outstanding decreased 4.12% in 2022, then grew 28.84% in 2023.
  • Over 5 years, Shares Outstanding stood at $90.5 million in 2021, then fell by 4.12% to $86.8 million in 2022, then increased by 28.84% to $111.8 million in 2023, then increased by 2.49% to $114.6 million in 2024, then grew by 11.06% to $127.3 million in 2025.
  • According to Business Quant data, Shares Outstanding over the past three periods came in at $127.3 million, $114.6 million, and $111.8 million for Q4 2025, Q4 2024, and Q4 2023 respectively.